CRA provided testimony in support of Masimo in its successful effort to refute monopolization, tying, and other antitrust counterclaims following a competitor’s infringement of its medical device patents. The team was led by Tim Snail and included Sharon Pang, Eyal Dvir, Omeed Alerasool, Ryne Belliston, Carl Hayden, Daniel Ladd, Joseph Marin, Flore Nouvel, and Sarah Black.
IP Literature Watch: January 2023
In this month’s IP Literature Watch we include a chapter discussing the current state of legal, economic, and policy research on standard-essential patents and...